Back to results
US 2006/0142282 A1Published application
Combination effective for the treatment of impotence
AssigneePfizer Inc.
InventorMichael Wyllie
Life of this patent
Estimating the term…
Abstract
This invention relates to the treatment of erectile dysfunction with a combination of (1) a compound selected from α-adrenergic receptor antagonists, and (2) a compound selected from agents which elevate cGMP levels. Sildenafil or a pharmaceutically acceptable salt thereof is preferred as the cGMP PDE elevator. Also included are compositions and kits comprising such impotence treating compounds.
Claims40
-30. (canceled)
A composition, comprising:
- (1) a first compound selected from α-adrenoceptor antagonists;
- (2) a second compound which elevates cGMP levels;
- and
- (3) a pharmaceutically acceptable carrier.
1 more element
-106. (canceled)
A kit comprising
- (1) a therapeutically effective amount of a first composition comprising a compound selected from α-adrenergic antagonists, plus a pharmaceutically acceptable carrier or diluent, in a first dosage form;
- (2) a therapeutically effective amount of a second composition comprising a compound selected from agents which elevate cGMP levels, plus a pharmaceutically acceptable carrier or diluent, in a second dosage form;
- and
- (3) container means for containing said first and second dosage forms.
1 more element
-114. (canceled)
-126. (canceled)
Dependencies are inferred from the claim text.